COMMUNIQUÉS West-GlobeNewswire

Sharecare acquires Window Channel Network, closes investment from Wells Fargo Strategic Capital

26/07/2018 - 18:00

Digital health company’s twelfth acquisition expands content capabilities in digital mindfulness, relaxation and meditation $20 million investment from Wells Fargo Strategic Capital brings Sharecare’s total funding to $ [...]

GUERBET : Revenue at June 30 2018

26/07/2018 - 17:48

€415.7M at constant exchange rates: +2.1% Villepinte, 26 July 2018 - Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is reporting revenue of €389.6M for the first [...]

GUERBET : Chiffre d'affaires au 30 juin 2018

26/07/2018 - 17:48

415,7 M€ à taux de change constant : +2,1% sur le 1 er semestre Villepinte, le 26 juillet 2018 - Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l'imagerie médicale, publie un [...]

ADMA Biologics Reports Successful Close-Out of its April 2018 FDA Compliance Inspection

26/07/2018 - 16:50

FDA Establishment Inspection Report (“EIR”) Received RAMSEY, N.J. and BOCA RATON, Fla., July 26, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA) (“ADMA” or the “Company”), a vertically integrated commercial [...]

Savara Announces Pricing of Public Offering of Common Stock

26/07/2018 - 15:15

AUSTIN, Texas, July 26, 2018 (GLOBE NEWSWIRE) -- Savara Inc. (Nasdaq:SVRA), an orphan lung disease company, today announced the pricing of an underwritten public offering of 4,250,000 shares of its common stock at a [...]

Software Veteran James Lim Joins Syapse as Senior Vice President of Product Development

26/07/2018 - 15:00

Lim will lead development of the Syapse software platform to support precision medicine initiatives at a growing number of health systems and life sciences partners SAN FRANCISCO, July 26, 2018 (GLOBE NEWSWIRE) -- [...]

Village Farms Increases Licensed Cannabis Footprint, On Track for More Value-Driving Milestones This Year -- CFN Media

26/07/2018 - 15:00

SEATTLE, July 26, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing [...]

Amarin Announces Approval for Vascepa® in United Arab Emirates

26/07/2018 - 14:48

Approval is Second Middle East Country to Approve Vascepa Sale Following Lebanon Earlier This Year BEDMINSTER, N.J. and DUBLIN, Ireland, July 26, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a [...]

UPDATE -- Tetra Bio-Pharma Confirms Meetings With FDA

26/07/2018 - 14:43

Type B & C Meetings Move TBP Closer to Market Approval ORLEANS, Ontario, July 26, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., (“ Tetra ” or the “ Company ”) a leader in cannabinoid-based drug discovery and [...]

Interpace Diagnostics Announces CIGNA’s Expansion of Coverage to Now Include ThyraMIR®

26/07/2018 - 14:37

National Plan Coverage for miRNA-based Classifier PARSIPPANY, N.J., July 26, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (IDXG) (“Interpace” or “the Company”), a fully integrated commercial and [...]

Surgery Partners, Inc. Announces Second Quarter 2018 Earnings Release Date and Conference Call Details

26/07/2018 - 14:31

NASHVILLE, Tenn., July 26, 2018 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced that the Company will release its [...]

Minerva Neurosciences to Report Second Quarter 2018 Financial Results and Business Updates on August 2, 2018

26/07/2018 - 14:30

Management to host conference call WALTHAM, Mass., July 26, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat [...]

Ultragenyx Announces First Patient Dosed in Phase 1/2 study of DTX401, a Gene Therapy for the Treatment of Glycogen Storage Disease Type Ia (GSDIa); FDA Grants Fast Track Designation to Gene Therapy Program

26/07/2018 - 14:30

NOVATO, Calif., July 26, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced [...]

Vericel to Present at the 38th Annual Canaccord Genuity Growth Conference

26/07/2018 - 14:30

CAMBRIDGE, Mass., July 26, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, [...]

Abeona Therapeutics Announces Leadership Appointments with Max Colao as Chief Commercial Officer

26/07/2018 - 14:30

NEW YORK and CLEVELAND, July 26, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life- [...]

Histogenics Corporation to Report Second Quarter 2018 Financial Results on August 9, 2018

26/07/2018 - 14:30

WALTHAM, Mass., July 26, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq:HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and restored function, announced [...]

Terra Tech Corp. Secures Stake in 10th Retail Permit

26/07/2018 - 14:30

IRVINE, Calif., July 26, 2018 (GLOBE NEWSWIRE) -- Terra Tech Corp . (OTCQX:TRTC) (“Terra Tech” or the “Company”), a vertically integrated cannabis-focused agriculture company, is pleased to announce that it has secured [...]

MPX to Report Fiscal 2018 Earnings on Monday, July 30, 2018

26/07/2018 - 14:30

TORONTO, July 26, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE:MPX) (OTC:MPXEF) today announced the Company will issue its fiscal 2018 full-year results release on July 30, 2018 [...]

Verona Pharma to Announce Interim Results for Six Months Ended June 30, 2018 and Provide Clinical Development Update

26/07/2018 - 14:30

LONDON, July 26, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]